KYNTRA BIO, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| VALONE FRANK H MD | Chief Medical Officer | Sale | 10,000 | $23.00 | $230,000 | 84,044 | Oct 19, 2015 |
| Yu K Peony | VP, Clinical Development | Sale | 5,000 | $24.00 | $120,000 | 192,904 | Oct 19, 2015 |
| Yu K Peony | VP, Clinical Development | Sale | 2,500 | $20.50 | $51,250 | 200,404 | Oct 16, 2015 |
| Neff Thomas B | Chief Executive Officer | Sale | 4,100 | $22.56 | $92,496 | 3,800,689 | Oct 15, 2015 |
| Neff Thomas B | Chief Executive Officer | Sale | 13,500 | $21.36 | $288,360 | 3,841,189 | Oct 2, 2015 |
| VALONE FRANK H MD | Chief Medical Officer | Option Exercise | 10,000 | $2.35 | $23,500 | 94,044 | Oct 1, 2015 |
| Neff Thomas B | Chief Executive Officer | Option Exercise | 8,078 | $2.90 | $23,426 | 3,858,720 | Sep 17, 2015 |
| Cotroneo Pat | VP, Finance and CFO | Option Exercise | 1,340 | $2.90 | $3,886 | 108,591 | Sep 15, 2015 |
| MADERO MIGUEL | — | Sale | 20,600 | $27.66 | $569,796 | 12,000 | Sep 11, 2015 |
| RIGGS RORY B | — | Sale | 25,571 | $27.56 | $704,737 | 480,200 | Sep 11, 2015 |
| Yu K Peony | VP, Clinical Development | Sale | 1,093 | $27.84 | $30,429 | 202,904 | Sep 10, 2015 |
| Cotroneo Pat | VP, Finance and CFO | Sale | 2,500 | $26.00 | $65,000 | 106,561 | Sep 8, 2015 |
| Neff Thomas B | Chief Executive Officer | Option Exercise | 9,469 | $2.35 | $22,252 | 3,862,751 | Sep 4, 2015 |
| Neff Thomas B | Chief Executive Officer | Tax Withholding | 2,282 | $22.84 | $52,121 | 3,870,813 | Sep 3, 2015 |
| Cotroneo Pat | VP, Finance and CFO | Tax Withholding | 657 | $22.84 | $15,006 | 106,561 | Sep 1, 2015 |
| VALONE FRANK H MD | Chief Medical Officer | Sale | 10,000 | $23.58 | $235,800 | 84,748 | Sep 1, 2015 |
| Yu K Peony | VP, Clinical Development | Tax Withholding | 657 | $22.84 | $15,006 | 203,997 | Sep 1, 2015 |
| MADERO MIGUEL | — | Option Exercise | 12,000 | $4.03 | $48,360 | 32,600 | Aug 17, 2015 |
| Neff Thomas B | Chief Executive Officer | Option Exercise | 9,469 | $2.35 | $22,252 | 3,873,095 | Aug 5, 2015 |
| VALONE FRANK H MD | Chief Medical Officer | Option Exercise | 10,000 | $2.35 | $23,500 | 94,748 | Aug 3, 2015 |
| Cotroneo Pat | VP, Finance and CFO | Option Exercise | 1,400 | $2.90 | $4,060 | 107,218 | Jul 27, 2015 |
| Neff Thomas B | Chief Executive Officer | Option Exercise | 9,469 | $2.35 | $22,252 | 3,881,157 | Jul 22, 2015 |
| Cotroneo Pat | VP, Finance and CFO | Sale | 5,381 | $23.23 | $125,001 | 105,818 | Jul 20, 2015 |
| VALONE FRANK H MD | Chief Medical Officer | Option Exercise | 1,000 | $2.35 | $2,350 | 85,748 | Jul 20, 2015 |
| Neff Thomas B | Chief Executive Officer | Option Exercise | 9,469 | $2.35 | $22,252 | 3,889,219 | Jul 9, 2015 |
| Yu K Peony | VP, Clinical Development | Sale | 2,600 | $22.83 | $59,358 | 204,654 | Jul 6, 2015 |
| Neff Thomas B | Chief Executive Officer | Sale | 500 | $23.93 | $11,965 | 3,891,843 | Jun 25, 2015 |
| Cotroneo Pat | VP, Finance and CFO | Option Exercise | 12,000 | $2.90 | $34,800 | 111,199 | Jun 12, 2015 |
| Yu K Peony | VP, Clinical Development | Tax Withholding | 657 | $17.50 | $11,498 | 210,035 | Jun 1, 2015 |
| Neff Thomas B | Chief Executive Officer | Tax Withholding | 2,282 | $17.50 | $39,935 | 3,905,343 | Jun 1, 2015 |
| Controneo Pat | VP, Finance and CFO | Tax Withholding | 657 | $17.50 | $11,498 | 99,199 | Jun 1, 2015 |
| VALONE FRANK H MD | Chief Medical Officer | Tax Withholding | 704 | $17.50 | $12,320 | 84,748 | Jun 1, 2015 |
| STERN JULIAN N | — | Option Exercise | 18,000 | $18.00 | $324,000 | 161,068 | May 20, 2015 |
| VALONE FRANK H MD | Chief Medical Officer | Tax Withholding | 2,906 | $21.39 | $62,159 | 85,452 | May 14, 2015 |
| Neff Thomas B | Chief Executive Officer | Tax Withholding | 9,337 | $21.39 | $199,718 | 3,907,625 | May 14, 2015 |
| Controneo Pat | VP, Finance and CFO | Tax Withholding | 2,712 | $21.39 | $58,010 | 99,856 | May 14, 2015 |
| Yu K Peony | VP, Clinical Development | Option Exercise | 4,000 | $2.90 | $11,600 | 206,692 | May 14, 2015 |
| Cotroneo Pat | VP, Finance and CFO | Sale | 5,932 | $54.61 | $323,947 | 168,334 | Mar 14, 2015 |
| Yu K Peony | VP, Clinical Development | Award / Grant | 32,068 | — | — | 203,068 | Mar 4, 2015 |
| VALONE FRANK H MD | Chief Medical Officer | Award / Grant | 34,358 | — | — | 88,358 | Mar 4, 2015 |
| Controneo Pat | VP, Finance and CFO | Award / Grant | 32,068 | — | — | 100,068 | Mar 4, 2015 |
| Neff Thomas B | Chief Executive Officer | Award / Grant | 73,800 | — | — | 3,916,962 | Mar 4, 2015 |
| Neff Thomas B | Chief Executive Officer | C | 60,946 | — | — | 60,946 | Nov 19, 2014 |
| Routti Jorma | — | C | 39,840 | — | — | 107,840 | Nov 19, 2014 |
| RIGGS RORY B | — | C | 233,699 | — | — | 605,713 | Nov 19, 2014 |
| STERN JULIAN N | — | C | 35,164 | — | — | 143,068 | Nov 19, 2014 |
| Neff Thomas B | Chief Executive Officer | C | 60,176 | — | — | 60,176 | Nov 19, 2014 |
| MADERO MIGUEL | — | C | 334,666 | — | — | 468,631 | Nov 19, 2014 |
| KEARNS THOMAS F JR | — | C | 179,536 | — | — | 185,536 | Nov 19, 2014 |
| Astellas Pharma Inc. | — | C | 4,968,367 | — | — | 4,968,367 | Nov 19, 2014 |